istaroxime
istaroxime is a pharmaceutical drug with 9 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 5 completed trials
Phase Distribution
Phase Distribution
4
Early Stage
5
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
71.4%
5 of 7 finished
28.6%
2 ended early
1
trials recruiting
9
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Randomized Evaluation of Istaroxime for Stabilization in Acute Heart Failure-Cardiogenic Shock
A Safety and Efficacy Trial of Istaroxime for Cardiogenic Shock Stage C
Istaroxime Infusion for 24 Hours in Chinese Healthy Volunteers
The Safety and Efficacy of Istaroxime for Pre-Cardiogenic Shock
The Clinical Study of the Safety and Efficacy of Istaroxime in Treatment of Acute Decompensated Heart Failure
Clinical Trials (9)
Randomized Evaluation of Istaroxime for Stabilization in Acute Heart Failure-Cardiogenic Shock
A Safety and Efficacy Trial of Istaroxime for Cardiogenic Shock Stage C
Istaroxime Infusion for 24 Hours in Chinese Healthy Volunteers
The Safety and Efficacy of Istaroxime for Pre-Cardiogenic Shock
The Clinical Study of the Safety and Efficacy of Istaroxime in Treatment of Acute Decompensated Heart Failure
Hemodynamic Response to Exercise in HFpEF Patients After Upregulation of SERCA2a
Safety and Efficacy Study of Istaroxime in Acute Decompensated Heart Failure Patients
Phase I Interaction Study of Istaroxime and Digoxin in Subjects With Stable Heart Failure
A Phase II Trial to Assess Hemodynamic Effects of Istaroxime in Pts With Worsening HF and Reduced LV Systolic Function
All 9 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 9